lobbying_activities: 3022630

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3022630	0df8e487-da12-45a7-b591-9bf2e41e912b	Q2	BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC	292972	BOEHRINGER INGELHEIM USA CORPORATION	2023	second_quarter	ANI	Issues related to Animal Health Issues related to One Health Issues Related to Compounding Animal Drugs from Bulk Substances Animal Drug User Fee Amendment of 2023 (H.R. 1418/S.1844) Foreign Animal Disease Prevention Surveillance and Rapid Response Act of 2023 (H.R. 3419/S.1666)	Agriculture, Dept of (USDA),Environmental Protection Agency (EPA),HOUSE OF REPRESENTATIVES,SENATE		890000	0	0	2023-07-20T09:39:18-04:00